CrossNorm: a novel normalization strategy for microarray data in cancers

CrossNorm: a novel normalization strategy for microarray data in cancers.

Normalization is essential to get rid of biases in microarray data for their accurate analysis. Existing normalization methods for microarray gene expression data commonly assume a similar global expression pattern among samples being studied. However, scenarios of global shifts in gene expressions are dominant in cancers, making the assumption invalid. To alleviate the problem, here we propose...

cDNA Microarray Data Normalization

Normalization of Microarray Data

DNA microarrays are a powerful technology for analysis of gene expression levels within cells. Both the cDNA and oligonucleotide technologies for microarrays are fairly young and are prone to a broad collection of errors and inaccuracies [KYML02]. In this paper we briefly discuss some sources of error and detail a variety of methods for normalizing the data with respect to some of these error s...

Extensive increase of microarray signals in cancers calls for novel normalization assumptions

When using microarray data for studying a complex disease such as cancer, it is a common practice to normalize data to force all arrays to have the same distribution of probe intensities regardless of the biological groups of samples. The assumption underlying such normalization is that in a disease the majority of genes are not differentially expressed genes (DE genes) and the numbers of up- a...

New Normalization Methods for CDNA Microarray Data

MOTIVATION The focus of this paper is on two new normalization methods for cDNA microarrays. After the image analysis has been performed on a microarray and before differentially expressed genes can be detected, some form of normalization must be applied to the microarrays. Normalization removes biases towards one or other of the fluorescent dyes used to label each mRNA sample allowing for prop...